Drug Approval | October 04, 2024
Shilpa Pharma Lifesciences receives CEP from EDQM for API, Desmopressin
This is used to treat central diabetes insipidus and bedwetting
This is used to treat central diabetes insipidus and bedwetting
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
The inspection conducted by EDQM at its Visakhapatnam facility
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
He holds a Master’s in Management from the National University of Singapore
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
Potential of Ayurveda’s contribution in global health system through various innovative practices
India has taken the lead in recognising NAFLD as a major non-communicable disease
Subscribe To Our Newsletter & Stay Updated
